Kalamazoo, MI, United States of America

Paul F Wiley


Average Co-Inventor Count = 2.0

ph-index = 3

Forward Citations = 30(Granted Patents)


Location History:

  • MI, US (1978)
  • Portage, MI (US) (1980 - 1985)
  • Kalamazoo, MI (US) (1976 - 1988)

Company Filing History:


Years Active: 1976-1988

Loading Chart...
19 patents (USPTO):Explore Patents

Title: **Paul F Wiley: Innovator in Antibiotic Development from Kalamazoo, MI**

Introduction

Paul F Wiley is an accomplished inventor based in Kalamazoo, MI, with a significant portfolio of 19 patents to his name. His work primarily focuses on advancements in antibiotic compounds and their applications.

Latest Patents

Two of his most notable recent patents include "Nobamycin and its analogs and process therefore" and "Paulomycin derivatives". The first invention pertains to a novel nogamycin with an unprecedented configuration, showing promise against various microorganisms. It also involves innovative methods to produce both substituted and unsubstituted nogamycin in a pure isomeric form. The second patent introduces novel compounds derived from the degradation of antibiotics paulomycin A and B, which are effective as ultraviolet light filters in materials such as plastics and fabrics.

Career Highlights

Throughout his career, Wiley has demonstrated a commitment to developing innovative and useful compounds. His work at The Upjohn Company has contributed to significant advancements in antibiotic research and applications, highlighting his expertise and inventive prowess in the field.

Collaborations

Paul F Wiley has collaborated with notable colleagues including Vincent P Marshall and David W Elrod. These partnerships have undoubtedly enhanced the scope and impact of his inventions in the pharmaceutical industry.

Conclusion

In summary, Paul F Wiley is a distinguished inventor whose contributions in the field of antibiotics have potential far-reaching implications. His inventive spirit and collaboration with talented colleagues continue to pave the way for advancements in pharmaceutical innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…